Document:

exv10w9

Exhibit 10.9

			
	 

	
	 	D’Anne Hurd

Vice President and General Counsel

Vice President for Business Development at Gateway Park

100 Institute Road • Worcester, MA 01609-2280

Phone: 508 831-5072 • Fax: 508 831-6530

e-mail: dhurd@wpi.edu

August 28, 2008

Tod Woolf, Ph.D.

RXi Pharmaceuticals Corporation

60 Prescott St.

Worcester, MA 01609

	Subject:	 	RXi Pharmaceuticals/Newgate Properties Lease Amendment

Dear Tod,

Per the discussions with Eric Overstrom, Director of the WPI Life Sciences and Bioengineering
Center (Newgate Properties, LLC), this letter is to serve as an amendment to the Lease between RXi
Pharmaceuticals Corporation and Newgate Properties, LLC dated September 25, 2007.

Beginning September 1, 2008, RXi Pharmaceuticals Corporation agrees to add to their premises the
Option Space shown in Exhibit D of the existing Lease. The addition of the Option Space to the
current Lease will occur in two stages under the following terms:

	 	•	 	Lease of room GP3208, containing 240 square feet of usable laboratory space, will
commence on September 1, 2008. Per the existing Lease terms, the rent will increase by a
rate of $34.00 per square foot per annum for a total rent increase of $680.00 per month.
Therefore, total monthly basic rent will be $15,716.50 beginning September 1, 2008 until
further notice.
	 
	 	•	 	In addition to the above, lease of the western most lab pod on 3rd floor
containing 610 usable square feet of laboratory space (the remaining 3rd floor
option space in shown in Exhibit D) will commence at a later date with at least 60 days
prior notice. Shared access to GP3238 is also provided. Per the existing Lease terms, the
rent will increase by a rate of $34.00 per square foot per annum ($1,728.33 per month).
Total monthly basic rent will be $17,444.33 beginning 60 days after notice, effective
through the remainder of the Lease term.

1

 

By signing this letter, we agree to the above terms.

	 	 	 	 	 
	 	Very truly yours,

LANDLORD:

Newgate Properties, LLC

 	 
	 	By:  	/s/ Jeffrey Solomon
 	 
	 	 	Jeffrey Solomon; Executive Vice President and CFO 	 
	 	 	Worcester Polytechnic Institute 	 
	 

TENANT:

RXi Pharmaceuticals Corporation

Acknowledged and Agreed to as of this 5th day of September, 2008.

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Tod Woolf
 	 
	 	 	Tod Woolf, Ph.D., President and CEO 	 
	 	 	RXi Pharmaceuticals Corporation 	 
	 

2exv10w10

Exhibit 10.10

	 	 	 

	

	 	D’Anne Hurd
 Vice President and General Counsel

Vice President for Business Development at Gateway Park

100 Institute Road • Worcester, MA 01609-2280

Phone: 508 831-5072 • Fax: 508 831-6530

 e-mail:dhurd@wpi.edu

November 4, 2008

Tod Woolf, Ph.D.

RXi Pharmaceuticals Corporation

60 Prescott St.

Worcester, MA 01609

Subject: RXi Pharmaceuticals/Newgate Properties Lease Amendment

Dear Tod,

Per your discussion with Eric Overstrom, Director of the WPI Life Sciences and Bioengineering
Center (Newgate Properties, LLC), this letter is to serve as an amendment to the Lease between RXi
Pharmaceuticals Corporation and Newgate Properties, LLC dated September 25, 2007.

Beginning November 5, 2008, RXi Pharmaceuticals Corporation agrees to add to their premises room
GP3009 (as shown on the attached floor plan) which contains 595 useable square feet of office
space. Per the discussed terms rent will increase by a rate of $34.00 per square foot per annum
($1,685.83 per month). Total monthly basic rent will be $17,402.33 beginning November 5,2008.

By signing this letter, we agree to the above terms.

Very truly yours,

	 	 	 	 	 
	LANDLORD:

Newgate Properties, LLC

 	 
	By:  	/s/ D’Anne Hurd
 	 
	 	D’Anne Hurd, Vice President and General Counsel  	 
	 	Worcester Polytechnic Institute 	 

1

 

	 	 	 	 	 
	TENANT:

RXi Pharmaceuticals Corporation

Acknowledged and Agreed to as of this day ______ of November, 2008.

 	 
	By:  	/s/ Tod Woolf
 	 
	 	Tod Woolf, Ph.D., President and CEO 	 
	 	RXi Pharmaceuticals Corporation 	 

2exv10w11

Exhibit 10.11

June 9, 2011

Mr. Jeffery Solomon

Worcester Polytechnic Institute

100 Institute Road

Worcester, MA 01609-2280

Dear Mr. Solomon

This letter is to serve as an amendment to the Lease between RXi Pharmaceuticals Corporation and
Newgate Properties, LLC dated September 25, 2007 and later amended on August 28, 2008 and again on
January 23, 2009.

Landlord and Tenant agree to amend:

Section 1.1 as follows:

Premises: For the period from June 16, 2011 to June 30, 2012, the portion of the first floor of the
Building consisting of approximately 2,882 square feet of office space and a portion of the third
floor consisting of approximately 2,425 square feet of laboratory space, all as more particularly
shown on Exhibit A attached hereto. On or before June 15, 2011, Tenant agrees to vacant all other
third floor premises consisting of approximately 595 square feet of office space and approximately
850 square feet of laboratory space and Landlord agrees to give Tenant a rent credit of $2047.00
(1,445 x $34.00 / 12 x .5).

Basic Rent: Notwithstanding any verbal or written statements to the contrary, the Landlord and
Tenant hereby agree that the schedule of Basic Rent shall be:

1. For the period from July 1, 2011 to July 31, 2011             $15,036.50

2. For the period from August 1, 2011 to June 30, 2012       $16,363.25 per month

     (Computed as 5,307 sf x $37.00 / 12 months)

Term: Notwithstanding any verbal or written statements to the contrary, the Landlord and Tenant
hereby agree that the Term of this Lease shall terminate on the earlier of:

1. June 30, 2012, or

2. 90 days from the date that Tenant provides written notice to Landlord of its intent to vacate the Premises and terminate the Lease.

[SIGNATURE PAGE FOLLOWS]

1

 

	 	 	 

	Tenant:
	 	 
	 
	 	 
	/s/ Mark Ahn

	 	June 10, 2011 

	 

	 	 
	Mark Ahn, Ph.D., President and CEO

RXi Pharmaceuticals Corporation

	 	(Date)
	 
	 	 
	Lessor:
	 	 
	 
	 	 
	/s/ Jeffrey S. Solomon

	 	6 /20/11 

	 

	 	 
	Jeffrey S. Solomon, EVP &CFO 

Worcester Polytechnic Institute

	 	(Date)

2exv10w3

Exhibit 10.3

EXPRESS SCRIPTS, INC.

2011 LONG-TERM INCENTIVE PLAN

STOCK OPTION GRANT NOTICE

          Notice is hereby given of the following option grant (the “Option”) to purchase shares of
common stock, $0.01 par value per share, of Express Scripts, Inc. (the “Company”) pursuant to the
following terms and conditions:

	 	 	 	 	 	 
	•

	 	Optionee:
	 	 
	 
	 
	 	 	 	 	 
	•

	 	Grant Date:
	 	 
	 
	 
	 	 	 	 	 
	•

	 	Exercise Price Per Share:
	$  
	 
	 
	 	 	 	 	 
	•

	 	Number of Option Shares:
	 
	 
	 
	 	 	 	 	 
	•

	 	Term/Expiration Date of Option:
	 
	 
	 
	 	 	 	 	 
	•

	 	Type of Option:
	___ Incentive Stock Option
	 
	 	 	 	 	 
	 

	 	 	___ Non-qualified Stock Option
	 
	•	 	Vesting Schedule: The shares of common stock granted pursuant to the Option
shall be vested and become exercisable in accordance with the following vesting
schedule:	 

	 	 	 	 	 	 
		 	—	 
		 	—	 
		 	—	 
	 
	 	 	 	 	 
	•	 	Other Provisions: The Option is granted subject to, and in accordance with,
the terms of the Stock Option Agreement (the “Option Agreement”) attached hereto as
Exhibit A, including Schedule 1 thereto, and the Express Scripts, Inc. 2011 Long-Term
Incentive Plan (the “Plan”) attached hereto as Exhibit B.

This Option is granted under, and governed by, the terms and conditions of this Grant
Notice, the Plan and the Option Agreement.

	 	 	 	 	 
	 	EXPRESS SCRIPTS, INC.

 	 
	 	By:  	 	 
	 	 	[NAME] 	 
	 	 	[TITLE] 	 
	 

Attachments:

Exhibit A—
Stock Option Agreement

Exhibit B—Express Scripts, Inc. 2011 Long-Term Incentive Plan

 

 

EXHIBIT A

EXPRESS SCRIPTS, INC.

2011 LONG-TERM INCENTIVE PLAN

STOCK OPTION AGREEMENT

     Express Scripts, Inc., a Delaware corporation (“Company”), has granted you (“Optionee”) an
option to purchase shares of common stock of the Company, $0.01 par value per share (“Common
Stock”), pursuant to the terms and conditions set forth in your Stock Option Grant Notice (“Grant
Notice”) and this Stock Option Agreement (“Option Agreement”).

     The Option is granted pursuant to the Express Scripts, Inc. 2011 Long-Term Incentive Plan, as
amended from time to time (the “Plan”), pursuant to which options, and other awards, may be granted
to key employees of the Company or an Affiliate. Except as otherwise specifically set forth
herein, all capitalized terms utilized herein (including on Schedule 1 hereto) shall have
the respective meanings ascribed to them in the Plan

     The details of your Option are as follows:

     1. Grant of Option. Pursuant to an action of the Board and/or the Committee, the
Company hereby grants to Optionee an option to purchase shares of Common Stock (the “Option”),
subject to the terms and conditions described herein. The number of shares of Common Stock subject
to your Option and the Exercise Price Per Share are set forth in the Grant Notice. If designated
in the Grant Notice as an Incentive Stock Option, this Option is intended to qualify as an
Incentive Stock Option under Section 422 of the Code. However, if this Option is intended to be an
Incentive Stock Option, to the extent that it exceeds the $100,000 rule of Code Section 422(d), it
shall nevertheless be treated as a Non-Qualified Stock Option.

     2. Term, Vesting and Forfeiture.

          (a) Term. This Option may be exercised only within the Term set forth in the Grant Notice,
and may be exercised during such Term only in accordance with the Plan and the terms of this Option
Agreement.

          (b) Time Vesting. The Option shall vest in one or more installments in accordance with the
Vesting Schedule set forth on the Grant Notice, with the vesting of each installment subject to the
Optionee’s continued employment with the Company through the applicable vesting date, subject to
the terms hereof and, where applicable, the terms of an Applicable Employment Agreement (as defined
below), if any.

          (c) Accelerated Vesting. Any Option, or portion thereof, which has not yet vested under
subparagraph (b) above shall, upon the occurrence of a Change in Control or the termination of the
Optionee’s employment with the Company, vest or be forfeited in accordance with the provisions of
the Plan, and the terms of this Agreement (including Schedule 1 hereto), and, where applicable, the
terms of an Applicable Employment Agreement.

          (d) Forfeiture of Option. If Optionee’s employment with the Company terminates for any reason,
Optionee shall forfeit all rights with respect to any portion of the Option that has not yet vested
as of the effective date of the termination, except to the extent such Award vests upon such
termination under Paragraph 2(c).

 

 

     3. Exercise of Option.

          (a) Right to Exercise. This Option is exercisable during its Term in accordance with the
Vesting Schedule set forth in the Grant Notice and the applicable provisions of the Plan and this
Option Agreement.

          (b) Method of Exercise. This Option is exercisable pursuant to the procedures for exercise
provided from time to time by the Company and/or by a third-party vendor selected by the Company.
The Option exercise shall require payment of the aggregate exercise price as to all exercised
shares. The method of payment of the aggregate exercise price shall be in a form approved by the
Company in accordance with Section 7(a)(ii) of the Plan. This Option shall be deemed to be
exercised upon receipt and approval by the Company (or the appropriate third party) of all required
exercise notices, together with full payment of the exercise price and such additional documents as
the Company (or the third-party vendor) may then require. The Company may cause, or authorize its
third-party to vendor to cause, the vested portion of this Option to automatically be exercised on
the Expiration Date for such Option, to the extent it has not previously been exercised or
forfeited.

     4. Incorporation of the Plan by Reference; Conflicting Terms. The Option is granted
under, and expressly subject to, the terms and provisions of the Plan, which terms and provisions
are incorporated herein by reference. Optionee hereby acknowledges receipt of a copy of the Plan
and agrees to be bound by all the terms and provisions thereof. In the event of any conflict
between the terms of the Plan and the terms of this Agreement, the terms and provisions of the Plan
shall govern.

     5. Non-Transferability of Option. This Option may not be transferred in any manner
otherwise than by will or by the laws of descent or distribution and may be exercised during the
lifetime of Optionee only by Optionee. The terms of the Plan and this Option Agreement shall be
binding upon the executors, administrators, heirs, successors and assigns of Optionee.

     6. Stockholder Rights. Optionee shall not have any stockholder rights with respect to
the shares of Common Stock granted pursuant to this Option until Optionee shall have exercised the
Option in accordance with Section 3 hereof.

     7. Adjustments Upon Changes in Capitalization or Corporate Acquisitions. Should any
change be made to the Common Stock by reason of any Fundamental Change, divestiture, distribution
of assets to stockholders (other than ordinary cash dividends), reorganization, recapitalization,
reclassification, stock dividend, stock split, reverse stock split, stock combination or exchange,
rights offering, spin-off or other relevant change, appropriate adjustments shall be made to (a)
the total number and/or class of securities subject to this Option, and (b) the Exercise Price Per
Share set forth in the Grant Notice in order to reflect such change and thereby preclude a dilution
or enlargement of benefits hereunder.

     8. Compliance with Laws and Regulations. Notwithstanding anything herein to the
contrary, no shares of Common Stock shall be issued pursuant to the exercise of this Option unless
such issuance and exercise complies with all relevant provisions of law and the requirements of any
stock exchange or quotation service upon which the shares of Common Stock are then listed.

     9. Committee Discretion. This Option has been granted pursuant to a determination
made by the Board and/or Committee. Notwithstanding anything to the contrary herein, and subject
to the limitations of the Plan, the Committee shall have plenary authority to: (a) interpret any
provision of this Agreement or the Option; (b) make any determinations necessary or advisable for
the administration of this Agreement or the Option; (c) make adjustments as it deems appropriate to
the aggregate number and type of securities available under this Agreement to appropriately adjust
for, and give effect to, any

 

 

Fundamental Change, divestiture, distribution of assets to stockholders (other than ordinary cash
dividends), reorganization, recapitalization, reclassification, stock dividend, stock split,
reverse stock split, stock combination or exchange, rights offering, spin-off or other relevant
change; and (d) otherwise modify or amend any provision hereof, or otherwise with respect to the
Option, in any manner that does not materially and adversely affect any right granted to Optionee
by the express terms hereof, unless required as a matter of law, subject to the limitations stated
in the Plan.

     10. Tax Withholding. At the time Optionee exercises his or her Option, in whole or in
part, the Company shall withhold from Optionee’s compensation any required taxes, including social
security and Medicare taxes, and federal, state and local income tax, with respect to the income
arising from the exercise of the Option under this Agreement. The Company shall have the right to
require the payment of any such taxes before delivering any shares of Common Stock upon the
exercise of the Option, or any portion thereof. Optionee may elect to have any such withholding
obligations satisfied by: (i) delivering cash; (ii) delivering part or all of the withholding
payment in previously owned shares of Common Stock; and/or (iii) irrevocably directing the Company
to reduce the number of shares that would otherwise be issued to Optionee upon the exercise of the
Option that number of whole shares of Common Stock having a fair market value, determined by the
Company, in its sole discretion, equal to the amount of tax required to be withheld, but not to
exceed the Company’s required minimum statutory withholding. If the Option is an Incentive Stock
Option, Optionee must immediately notify the Company in writing in the event Common Stock received
pursuant to the Option is sold on or before the later of (a) two years after the Grant Date (as set
forth in the Grant Notice), or (b) one year after the exercise date of the Option.

     11. Electronic Delivery. The Company may choose to deliver certain statutory or
regulatory materials relating to the Plan in electronic form, including without limitation
securities law disclosure materials. Without limiting the foregoing, by accepting this Option,
Optionee hereby agrees that the Company may deliver the Plan prospectus and the Company’s annual
report to Optionee in an electronic format. If at any time Optionee would prefer to receive paper
copies of any document delivered in electronic form, the Company will provide such paper copies
upon written request to the Investor Relations department of the Company.

     12. No Right to Continued Employment. Nothing in this Agreement shall be deemed to
create any limitation or restriction on such rights as the Company otherwise would have to
terminate the employment of Optionee at any time for any reason.

     13. Entire Agreement. This Agreement, including Schedule 1 hereto, and the Plan
contain the entire understanding of the parties with respect to the subject matter hereof and
supersede all prior agreements, understandings and negotiations between the parties except to the
extent that the vesting and/or forfeiture of this Option is specifically addressed by any
employment agreement between the Company and Optionee (an “Applicable Employment Agreement”), in
which instance the relevant terms of such Applicable Employment Agreement shall be incorporated
herein and deemed to be a part of this Agreement, and, in the event of any conflict between the
terms of this Agreement regarding the vesting or forfeiture of the Option, and the terms of an
Applicable Employment Agreement (if any), the terms and provisions of the Applicable Employment
Agreement shall govern. In addition, any references in any such Applicable Employment Agreement to
the Express Scripts, Inc. 2000 Long-Term Incentive Plan shall also be deemed to refer to the Plan
as appropriate.

     14. Governing Law. To the extent federal law does not otherwise control, this
Agreement shall be governed by the laws of Delaware, without giving effect to principles of
conflicts of laws.

 

 

SCHEDULE 1 TO EXHIBIT A

TERMINATION AND CHANGE IN CONTROL PROVISIONS UNDER THE

EXPRESS SCRIPTS, INC.

2011 LONG-TERM INCENTIVE PLAN

STOCK OPTION AGREEMENT

   I. Termination of Employment

     (A) Generally. Except as specifically set forth herein, or in an Applicable Employment
Agreement, any portion of the Option that has not vested as of the date of the termination of
Optionee’s employment by the Company or any Affiliate shall terminate as of such date, and the
unvested portion of the Option shall be forfeited to the Company without payment therefor.

     (B) Death. If Optionee’s employment terminates because of his or her death, then the Option,
to the extent it has not expired or been terminated, shall vest and become exercisable in full, and
may be exercised by the Optionee’s Successor at any time, or from time to time, within one year
after the date of Optionee’s death.

     (C) Disability. If Optionee’s employment terminates because of Disability, then the Option,
to the extent it has not expired or been terminated, shall vest and become exercisable in full, and
Optionee or Optionee’s Successor may exercise such Option at any time, or from time to time, within
one year after the date of Optionee’s Disability.

     (D) Retirement. If Optionee’s employment terminates because of Retirement, the Option, to the
extent it has not expired or been terminated, shall vest and become exercisable in full, and
Optionee may exercise such Option at any time, or from time to time, within one year after the date
of Retirement.

     (E) Termination for Cause. Upon termination of Optionee’s employment by the Company for
Cause, the Option, to the extent not previously exercised, shall immediately terminate.

     (F) Reasons other than Death, Disability, Retirement or Termination for Cause. If Optionee’s
employment terminates for any reason other than death, Disability, Retirement or by the Company for
Cause, then the Option, if it is a Non-Qualified Stock Option, to the extent it has not expired or
been terminated, shall remain exercisable for one year after termination of Optionee’s employment
(and if the Option is an Incentive Stock Option, to the extent it has not expired or been
terminated, the Option shall remain exercisable for three months after termination of Optionee’s
employment), but only to the extent that such Option was exercisable immediately prior to
Optionee’s termination of employment.

     (G) Expiration of Term. Any portion of the Option that remains unexercisable upon termination
of employment (after taking into account the foregoing paragraphs (A)-(F) and/or the provisions of
any Applicable Employment Agreement) shall terminate immediately upon such termination of
employment. Any portion of the Option that is, or becomes, exercisable upon termination of
employment which is not exercised within the applicable period set forth in the foregoing
paragraphs (A)-(F) (or pursuant to an Applicable Employment Agreement ) shall terminate as of the
end of the applicable period described in such paragraphs (or pursuant to an Applicable Employment
Agreement); provided, however, that the Company may cause, or authorize its third-party to vendor
to cause, any remaining vested portion of the Option to automatically be exercised on the last date
of the applicable period, to the extent it has not previously been exercised or forfeited.
Notwithstanding the foregoing, or any other provision of the Plan, the Stock Option Agreement, the
Grant Notice, this Schedule 1, or an

 

 

Applicable Employment Agreement to the contrary, in no event shall the Option be exercisable
after expiration of the Term.

   II. Change in Control

     (A) Acceleration of Vesting Upon Change in Control After Which No Public Market for Company or
Exchange Stock Exists

               (i) Acceleration of Vesting. Upon the occurrence of a Change in Control after which
there will be no generally recognized U.S. public market for the Company’s Common Stock or any
common stock for which the Company’s Common Stock is exchanged, the Option, to the extent it has
not expired or been terminated, shall, to the extent not yet exercisable, vest and become
exercisable in full.

               (ii) Company Payment. Upon the occurrence of a Change in Control transaction after
which there will be no generally recognized U.S. public market for the Company’s Common Stock or
any common stock for which the Company’s Common Stock is exchanged, on the Change in Control Date
the Option shall be automatically cancelled without further action by the Company or the
Optionee,, and the Company shall provide payment in connection with such cancellation at a per
share price equal to the excess (if any) of the Change in Control Price (as defined below) over the
exercise price of the Option. The Change in Control Price shall mean the value, expressed in
dollars, as of the date of receipt of the per share consideration received by the Company’s
stockholders whose stock is acquired in a transaction constituting a Change in Control. In case
such all or part of such consideration shall be in a form other than cash, the value of such
consideration shall be as determined in good faith by a majority of the Incumbent Board, or if
there shall be none, by a majority of the Board of Directors based on a written opinion by a
nationally recognized investment banking firm, whose determination shall be described in a
statement furnished to Participants.

     (B) Acceleration of Vesting Upon Other Change in Control Transactions. Upon the occurrence of
a Change in Control after which there remains a generally recognized U.S. public market for the
Company’s Common Stock or for any common stock for which the Company’s Common Stock is exchanged,
the Option, to the extent it has not expired or been terminated, shall vest and become exercisable
in full and shall remain exercisable for the remainder of the Term.

     (C) Options Not Assumed. Notwithstanding anything herein to the contrary, the Committee may
provide for such other treatment of the Option as the Committee may determine in its sole
discretion with respect to the Option if it is not assumed or is cancelled in connection with a
Change in Control.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}]]